Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene–environment rat model of depression

An animal model of depression combining genetic vulnerability and early-life stress (ELS) was prepared by submitting the Flinders Sensitive Line (FSL) rats to a standard paradigm of maternal separation. We analysed hippocampal synaptic transmission and plasticity in vivo and ionotropic receptors for...

Full description

Saved in:
Bibliographic Details
Published inThe international journal of neuropsychopharmacology Vol. 12; no. 4; pp. 553 - 559
Main Authors Ryan, Ben, Musazzi, Laura, Mallei, Alessandra, Tardito, Daniela, Gruber, Suzanne H. M., El Khoury, Aram, Anwyl, Roger, Racagni, Giorgio, Mathé, Aleksander A., Rowan, Michael J., Popoli, Maurizio
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.05.2009
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An animal model of depression combining genetic vulnerability and early-life stress (ELS) was prepared by submitting the Flinders Sensitive Line (FSL) rats to a standard paradigm of maternal separation. We analysed hippocampal synaptic transmission and plasticity in vivo and ionotropic receptors for glutamate in FSL rats, in their controls Flinders Resistant Line (FRL) rats, and in both lines subjected to ELS. A strong inhibition of long-term potentiation (LTP) and lower synaptic expression of NR1 subunit of the NMDA receptor were found in FSL rats. Remarkably, ELS induced a remodelling of synaptic plasticity only in FSL rats, reducing inhibition of LTP; this was accompanied by marked increase of synaptic NR1 subunit and GluR2/3 subunits of AMPA receptors. Chronic treatment with escitalopram inhibited LTP in FRL rats, but this effect was attenuated by prior ELS. The present results suggest that early gene–environment interactions cause lifelong synaptic changes affecting functional and molecular aspects of plasticity, partly reversed by antidepressant treatments.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1461-1457
1469-5111
1469-5111
DOI:10.1017/S1461145708009607